Navigation Links
CEL-SCI Corporation to Launch Aseptic Filling for Stem Cell Produced Therapies and Other Biological Products
Date:3/10/2009

VIENNA, Va., March 10 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (NYSE Alternext US: CVM) announced today that it is planning to launch a new manufacturing process that could allow drugs developed using stem cells and other biological products to maintain their potency and thereby potentially also their shelf life. The availability of this new process developed by CEL-SCI may also significantly accelerate the time to market by eliminating complicated and time consuming validation studies and tests required when these products are filled at room temperature.

CEL-SCI's new state-of-the-art manufacturing facility near Baltimore, Maryland, where it expects to manufacture its lead cancer product Multikine(R) for a pivotal Phase III trial, will be used for the process known as cold 4 degrees Celsius Aseptic Filling on a contract basis to stem cell and biologic companies, academic institutions and commercial media suppliers. The facility will allow CEL-SCI to perform cold 4 degrees Celsius aseptic filling of small volume parenteral drug products and sterile media products. The use of a cold 4 degrees Celsius fill, as opposed to the normal room temperature fill, significantly increases the probability of maintaining drug activity, potency and thus potentially extending the shelf life of new biological and stem cell produced products. CEL-SCI will be the only company providing this cold 4 degrees Celsius filling service on a contract basis to other companies and academic institutions.

Many stem cell derived products are expected to have similar requirements to biologically derived drug products, such as Multikine, allowing CEL-SCI to utilize many of the same clean rooms and production facilities. Many Biologic products benefit from being maintained at refrigerated (cold) temperatures, usually between 2 and 8 degrees Celsius throughout their manufacturing process and storage. CEL-SCI's unique, cold aseptic filling suite can
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. CEL-SCI Corporation Announces 2008 Financial Results
2. CEL-SCI Corporation Releases Letter to Shareholders
3. Updated Pictures of CEL-SCI Manufacturing Facility Available Online
4. CEL-SCI Takes Delivery of New Manufacturing Facility
5. CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results
6. CEL-SCI Announces Exclusive Licensing Agreement with Teva for Cancer Drug Multikine
7. CEL-SCI CORPORATION Manufacturing Facility for Pivotal Phase III Cancer Trial Scheduled to Be Completed During 2008 Third Quarter
8. CEL-SCI to Present at the Noble Financial Conference
9. Waters Corporation Continues to Meet Todays Challenges for Improved Laboratory Operations with New Products at Pittcon 2009
10. China Bio-Immunity Corporation - Rabies Vaccine Recall
11. CUREXO Technology Corporation Announces New Headquarters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Can economic incentives such as gift cards, T-shirts, ... public to increase their donations of blood? , A ... School Assistant Professor Mario Macis says the answer ... of recent research that supports their argument, the three ... Science that the World Health Organization and national blood ...
(Date:5/23/2013)...  Rahal Letterman Lanigan Racing (RLL) and StemCyte, Inc., ... banking and therapeutics, announced today that StemCyte has become ... Indy car driven by James Jakes ... IndyCar 2013 season.   StemCyte, Inc. and Rahal ... of umbilical cord blood banking and its educational initiative ...
(Date:5/23/2013)... LAGUNA HILLS, Calif. , May 23, 2013 /PRNewswire-USNewswire/ ... CA recently became the first hospital on ... site robotic technology. This new surgical option provides women ... Marc Winter , ... gynecologist and surgeon and medical director of minimally ...
(Date:5/23/2013)... Z Trim Holdings, Inc. (OTC Markets: ZTHO), ... of industries, announced that Chef Erin Ryan ... year,s National Restaurant Association ("NRA") NRA Show, which was ... Research Chefs Association.  Chef Ryan spoke on the subject ... and the Ugly," joining four other prestigious panelists including: ...
Breaking Biology Technology:Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 2StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 3Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 2Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 3
... Israel, Nov. 29 Protalix,BioTherapeutics, Inc. (Amex: PLX ... the close of business on December 24, 2007, as ... and to vote at, the,Company,s 2007 Annual Meeting of ... Meeting of Shareholders will be held on,January 31, 2008, ...
... the treatment ... disease ... Symbol: RVX, CALGARY, Nov. 29 /PRNewswire-FirstCall/ - Resverlogix Corp.,("Resverlogix") (TSX:RVX) is pleased ... of the very prestigious,Technology Pioneer Award in recognition of its NexVas(TM) Plaque Removal,program. ...
... Jerusalem Global Ventures today,announced that it will soon ... fund. The Fund will invest in private Israeli related,technology ... three years and,have a proven business model. First closing ... who founded Jerusalem Global in 1994, notes that,"Unlike the ...
Cached Biology Technology:Protalix BioTherapeutics Sets Record Date for Annual Meeting of Shareholders 2Protalix BioTherapeutics Sets Record Date for Annual Meeting of Shareholders 3Resverlogix Honoured with World Economic Forum Technology Pioneer Award 2Resverlogix Honoured with World Economic Forum Technology Pioneer Award 3Resverlogix Honoured with World Economic Forum Technology Pioneer Award 4Resverlogix Honoured with World Economic Forum Technology Pioneer Award 5Jerusalem Global Ventures Announces $200 Million Growth Equity Fund 2
(Date:5/23/2013)... with autologous cord blood. Following a cardiac arrest with ... been in a persistent vegetative state with minimal ... the cord blood containing stem cells, the symptoms improved ... speak simple sentences and to move. "Our findings, along ... doubts about the effectiveness of the new therapy", says ...
(Date:5/22/2013)... NEW YORK CITY, May 22, 2013 U.S. Forest ... multi-disciplinary team that, with funding from the TKF Foundation, ... spaces help communities and individuals recover from tragedy. , ... is one of six projects selected for grant funding. ... spaces and sacred spaces in recovery and resiliency, the ...
(Date:5/22/2013)... 22, 2013)The omega 3 fatty acids in fish oil ... much so that the American Heart Association currently recommends ... particularly fatty varieties rich in omega 3s. However, the ... In a new study, scientists led by Jason R. ... phenomenon by providing evidence that fish oil might specifically ...
Breaking Biology News(10 mins):First successful treatment of pediatric cerebral palsy with autologous cord blood 2'Landscapes of Resilience' to study how people use nature as a source of recovery 2Fish oil may help the heart beat mental stress 2
... and US scientists has found there has been a massive ... the coast of Antarctica.,Comparing detailed measurements taken during the Australian ... data dating back to 1970, scientists estimate there has been ... volume of Antarctic Bottom Water, the cold dense water that ...
... IMPACT World+, the first worldwide regionalized life cycle impact ... during the 6th SETAC World Congress / SETAC Europe ... this innovative undertaking spearheaded by a team of leading ... production and consumption of goods and services generate significant ...
... able to target and destroy triple negative breast cancer, ... access journal Breast Cancer Research . Researchers from ... was able to destroy breast cancer cells and reduce ... cancers are found at diagnosis to be triple negative. ...
Cached Biology News:Latest Southern Ocean research shows continuing deep ocean change 2Latest Southern Ocean research shows continuing deep ocean change 3Launch of IMPACT World+ 2Blocking DNA: HDAC inhibitor targets triple negative breast cancer 2
... CHEMICON APO-BRDU Kit is a ... breaks and total cellular DNA to detect ... kit contains the instructions and reagents required ... and negative control cells for assessing reagent ...
... with temperature probe, 100-120 and 220-240 V, supports ... and 400 W. The temperature probe is used ... degrees C during electrophoresis. Built-in infrared capability allows ... are provided. Dimensions are 27.5 x 34 x ...
The Trans-Blot Plus gel and cassette assembly tray is used to hold the Trans-Blot Plus gel holder cassette, buffer, and other materials for the gel and membrane sandwich during their assembly....
Criterion staining and blotting trays are plastic trays designed for staining one or two Criterion gels or performing western blot detection. The trays have a working capacity of up to 500 ml. Suppli...
Biology Products: